Cathie Wood's ARK Invest Buys Over 8 Million Shares of Ginkgo Bioworks

Investing

Published: October 7, 2021 8:05 am

Last Updated: October 7, 2021 12:39 pm

A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge buy on Wednesday. Specifically, these funds bought roughly $87 million worth of Ginkgo Bioworks Holdings Inc. (NYSE: DNA), as the prices of these funds were very mixed on Wednesday. Note though that they are up a fair amount in the past year.

ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 1,525,065 shares of Ginkgo, and ARK Innovation ETF (NYSEARCA: ARKK) bought 6,739,168 shares. At Wednesday’s closing prices, this would have valued the sales at roughly $87.5 million altogether. Even though this is a small fraction of their total holdings, every little bit counts. The Genomic Revolution ETF is up less than 8% and the other is up 17% in the past year.

Check out all the ARK Invest purchases for Wednesday as well:

Fund	Ticker	Name	Shares
ARKF	TDOC	TELADOC HEALTH	41,819
ARKG	SURF	SURFACE ONCOLOGY	179,161
ARKG	QSI	QUANTUM-SI	120,419
ARKG	SLGC	SOMALOGIC	303,876
ARKG	DYNS	DYNAMICS SPECIAL PURPOSE	600
ARKG	DNA	GINKGO BIOWORKS	1,525,065
ARKG	BEAM	BEAM THERAPEUTICS	75,862
ARKG	ADPT	ADAPTIVE BIOTECHNOLOGIES	103,497
ARKK	TWOU	2U	42,060
ARKK	SSYS	STRATASYS	77,800
ARKK	SGFY	SIGNIFY HEALTH	325,861
ARKK	PATH	UIPATH	580,632
ARKK	PACB	PACIFIC BIOSCIENCES OF CALIFORNIA	57,511
ARKK	BEAM	BEAM THERAPEUTICS	17,763
ARKK	DNA	GINKGO BIOWORKS	6,739,168
ARKQ	ACHR	ARCHER AVIATION	58,153
ARKQ	BLDE	BLADE AIR MOBILITY	148,623
ARKQ	VLD	VELO3D	106,782
ARKQ	MKFG	MARKFORGED	81,700
ARKQ	NIU	NIU TECHNOLOGIES	15,528
ARKW	SQ	SQUARE	13,256
ARKW	TDOC	TELADOC HEALTH	31,367
ARKW	VUZI	VUZIX	103,245
ARKX	PRNT	3D PRINTING ETF	1,022

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.